Skip to main content
SpringerLink
Log in

Autologous peripheral blood stem cell transplantation in children with non-Hodgkin’s lymphoma: a report from the Korean society of pediatric hematology-oncology

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

An Erratum to this article was published on 02 December 2006

Abstract

Recent development of stratified chemotherapeutic regimens has rapidly improved the survival rate of non-Hodgkin’s lymphoma (NHL) of childhood. Despite these improvements, the outcome for children with recurrent or refractory NHL remains dismal. We explored the use of high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (HDC/PBSCT) for children with either refractory or recurrent NHL, and we evaluated various factors influencing outcome of HDC/PBSCT. Thirty-three patients underwent HDC/PBSCT in 11 institutes were enrolled. All patients had refractory or recurrent NHL. Sex, stage at diagnosis, histologic subtype (lymphoblastic, Burkitt’s, and large-cell lymphoma), LDH level at diagnosis, disease status at transplantation, and preparative regimens for HDC/PBSCT were explored. In regard to the patients, six had Burkitt’s lymphoma, 13 had lymphoblastic lymphoma, and 14 had large-cell lymphoma. The 2-year event-free survival (EFS) was 59.1±9.3%. The EFS for Burkitt’s, lymphoblastic, and large-cell lymphoma was 66.7±27.2, 50.5±14.8, and 82.1±11.7%, respectively. In comparison with lymphoblastic and non-lymphoblastic lymphoma, the relative risk for lymphoblastic lymphoma was higher than the others (P=0.037). EFS between anaplastic large-cell and diffuse large-cell lymphoma was 100 and 55.6±24.9%, respectively (P=0.106). Status at transplantation was the most predictive factor for the survival after HDC/PBSCT (EFS for CR 70.8±9.5% vs non-CR 20.0±17.9%, P=0.008). Transplantation-related complications were minimal, and infection was the most prevalent complication. HDC/PBSCT is considered applicable to recurrent or refractory pediatric NHL patients safely and it could replace conventional chemotherapy. In this study, children with CR status at the time of HDC/PBSCT showed higher survival rate. However, refractory or recurrent lymphoblastic lymphoma patients showed dismal results. Therefore, new therapeutic modalities may be needed for this group of NHL patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sandlund JT, Downing JR, Crist WM (1996) Non-Hodgkin’s lymphoma in childhood. N Engl J Med 334:1238–1248

    Article  PubMed  CAS  Google Scholar 

  2. Seidemann K, Tiemann M, Schrappe M et al (2001) Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 97:3699–3706

    Article  PubMed  CAS  Google Scholar 

  3. Reiter A, Schrappe M, Tiemann M et al (1994) Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899–908

    PubMed  CAS  Google Scholar 

  4. Reiter A, Schrappe M, Tiemann M et al (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 94:3294–3306

    PubMed  CAS  Google Scholar 

  5. Reiter A, Schrappe M, Ludwig WD et al (2000) Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95:416–421

    PubMed  CAS  Google Scholar 

  6. Appelbaum FR, Deisseroth AB, Graw RG Jr et al (1978) Prolonged complete remission following high dose chemotherapy of Burkitt’s lymphoma in relapse. Cancer 41:1059–1063

    Article  PubMed  CAS  Google Scholar 

  7. Capria S, Vignetti M, Proia A et al (1996) Autologous bone marrow transplantation in 44 patients with aggressive non-Hodgkin’s lymphoma at University “La Sapienza” of Rome. Leuk Lymphoma 23:147–151

    Article  PubMed  CAS  Google Scholar 

  8. Philip T, Biron P, Maraninchi D et al (1985) Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin’s lymphoma. Br J Haematol 60:599–609

    Article  PubMed  CAS  Google Scholar 

  9. Philip T, Biron P, Philip I et al (1986) Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt’s lymphoma (30 courses on 28 patients: a 5-year experience). Eur J Cancer Clin Oncol 22:1015–1027

    Article  PubMed  CAS  Google Scholar 

  10. Philip T, Guglielmi C, Hagenbeek A et al (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma. N Engl J Med 333:1540–1545

    Article  PubMed  CAS  Google Scholar 

  11. Rapoport AP, Lifton R, Constine LS et al (1997) Autotransplantation for relapsed or refractory non-Hodgkin’s lymphoma (NHL): long-term follow-up and analysis of prognostic factors. Bone Marrow Transplant 19:883–890

    Article  PubMed  CAS  Google Scholar 

  12. Philip T, Hartmann O, Biron P et al (1988) High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin’s lymphoma. J Clin Oncol 6:1118–1124

    PubMed  CAS  Google Scholar 

  13. Bureo E, Ortega JJ, Munoz A et al (1995) Bone marrow transplantation in 46 pediatric patients with non-Hodgkin’s lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children. Bone Marrow Transplant 15:353–359

    PubMed  CAS  Google Scholar 

  14. Loiseau HA, Hartmann O, Valteau D et al (1991) High-dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non-Hodgkin’s lymphoma. Bone Marrow Transplant 8:465–472

    PubMed  CAS  Google Scholar 

  15. O’Leary M, Ramsay NK, Nesbit ME Jr et al (1983) Bone marrow transplantation for non-Hodgkin’s lymphoma in children and young adults. A pilot study. Am J Med 74:497–501

    Article  PubMed  CAS  Google Scholar 

  16. Attarbaschi A, Dworzak M, Steiner M et al (2005) Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group. Pediatr Blood Cancer 44:70–76

    Article  PubMed  Google Scholar 

  17. Sandlund JT, Bowman L, Heslop HE et al (2002) Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL. Cytotherapy 4:253–258

    Article  PubMed  CAS  Google Scholar 

  18. Fanin R, Ruiz de Elvira MC, Sperotto A et al (1999) Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 23:437–442

    Article  PubMed  CAS  Google Scholar 

  19. Gorczynska E, Toporski J, Boguslawska-Jaworska J, Slociak M (1998) High-dose chemotherapy with autologous hematopoietic progenitor cell transplantation in children with high-risk NHL and ALL-preliminary results. Bone Marrow Transplant 22(Suppl 4):S107–S109

    PubMed  Google Scholar 

  20. Kobrinsky NL, Sposto R, Shah NR et al (2001) Outcomes of treatment of children and adolescents with recurrent non-Hodgkin’s lymphoma and Hodgkin’s disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children’s Cancer Group Study CCG-5912. J Clin Oncol 19:2390–2396

    PubMed  CAS  Google Scholar 

  21. Murphy SB (1980) Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7:332–339

    PubMed  CAS  Google Scholar 

  22. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep Part 1 50:163–170

    CAS  Google Scholar 

  23. Cox DR (1972) Regression models and life tables. J R Stat Soc B 34:187–220

    Google Scholar 

  24. Ladenstein R, Pearce R, Hartmann O et al (1997) High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt’s lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry. Blood 90:2921–2930

    PubMed  CAS  Google Scholar 

  25. Wojcik B, Kowalczyk JR, Chybicka A et al (2004) Autologous stem-cell transplantations in children with non-Hodgkin lymphomas. Przegl Lek 61(Suppl 2):53–56

    PubMed  Google Scholar 

  26. Levine JE, Harris RE, Loberiza FR Jr et al (2003) A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood 101:2476–2482

    Article  PubMed  CAS  Google Scholar 

  27. Philip T, Hartmann O, Pinkerton R et al (1993) Curability of relapsed childhood B-cell non-Hodgkin’s lymphoma after intensive first line therapy: a report from the Societe Francaise d’Oncologie Pediatrique. Blood 81:2003–2006

    PubMed  CAS  Google Scholar 

  28. Anderson JR, Wilson JF, Jenkin DT et al (1983) Childhood non-Hodgkin’s lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). N Engl J Med 308:559–565

    Article  PubMed  CAS  Google Scholar 

  29. Cabanillas F, Hagemeister FB, McLaughlin P et al (1987) Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 5:407–412

    PubMed  CAS  Google Scholar 

  30. Philip T, Armitage JO, Spitzer G et al (1987) High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma. N Engl J Med 316:1493–1498

    Article  PubMed  CAS  Google Scholar 

  31. Gustavsson A, Osterman B, Cavallin-Stahl E (2003) A systematic overview of radiation therapy effects in non-Hodgkin’s lymphoma. Acta Oncol 42:605–619

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, School of Medicine, Yonsei University, 134 Sinchon-dong, Seodaemun-gu, Seoul, 120-752, South Korea

    Sung Chul Won, Jung Woo Han, Seung Yeon Kwon & Chuhl Joo Lyu

  2. Department of Pediatrics, College of Medicine, Seoul National University, Seoul, South Korea

    Hee-Young Shin & Hyo-Seop Ahn

  3. Department of Pediatrics, College of Medicine, Chonnam University, Kwangju, South Korea

    Tae Ju Hwang

  4. Department of Pathology, School of Medicine, Yonsei University, Seoul, South Korea

    Woo Ick Yang

Authors
  1. Sung Chul Won
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jung Woo Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seung Yeon Kwon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hee-Young Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hyo-Seop Ahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tae Ju Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Woo Ick Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chuhl Joo Lyu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chuhl Joo Lyu.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00277-006-0225-y

Appendix

Appendix

Table 3 Participating investigators: Korean Society of Pediatric Hematology–Oncology
Full size table

Rights and permissions

Reprints and permissions

About this article

Cite this article

Won, S.C., Han, J.W., Kwon, S.Y. et al. Autologous peripheral blood stem cell transplantation in children with non-Hodgkin’s lymphoma: a report from the Korean society of pediatric hematology-oncology. Ann Hematol 85, 787–794 (2006). https://doi.org/10.1007/s00277-006-0169-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-006-0169-2

Keywords

Search

Navigation